GHK-Cu 100mg

This guide covers the 100mg vial format of GHK-Cu — the same tripeptide-copper complex described in the dedicated 50mg guide (Gly-His-Lys coordinated with a single copper(II) ion, effective complex weight near 403.9 g/mol), supplied at double the per-vial content. The molecule, the copper-coordination chemistry, and the proposed research mechanisms are identical to the 50mg form. What this guide adds is the practical context for protocols that consume more than 50mg before the stability window of a reconstituted solution closes — and the consistency considerations that come with preparing a larger working volume from a single batch.

GHK-Cu research with consumable-heavy designs falls into a few common categories: topical-formulation pilot work where a single base formulation must be prepared at sufficient volume to cover a controlled-condition arm; multi-cohort dermal-research animal studies; and extended-timepoint regenerative-tissue protocols. In each case, the per-experiment peptide consumption can outpace the 50mg vial's per-reconstitution working volume. Choosing the 100mg vial reduces the number of reconstitution events across the protocol — which in turn reduces the cumulative copper-coordination variability that can arise from repeated freeze-thaw cycles.

GHK-Cu 100mg is sold strictly for laboratory and research use. It is not approved by the FDA or any other regulatory body for human or veterinary use, and nothing in this guide constitutes guidance for human administration.

The blue color of GHK-Cu powder comes from the copper(II) coordination — a useful built-in visual check on supplied material. At larger vial scale, the consistency of that coloration becomes a meaningful inter-batch quality signal: significant fading, mottling, or color variation across the larger powder volume can indicate uneven copper loading and is worth checking on receipt. The Certificate of Analysis is the authoritative document, but the visual check is a fast first-pass screen.

Every batch of MHS Longevity GHK-Cu 100mg is submitted to an independent third-party laboratory before release — the same HPLC + Mass Spectrometry + copper-form verification protocol applied to the 50mg vial:

Lyophilized GHK-Cu at -20°C is stable across reasonable timeframes regardless of vial size. The handling difference for the 100mg vial is volume-related: a single reconstitution produces double the working solution of a 50mg vial, which makes single-use aliquoting more practical. Protect from prolonged light exposure — the copper coordination is more photosensitive than the peptide alone, and the larger powder volume in a 100mg vial spends more time exposed during weighing/dispensing operations if not handled carefully. Standard aseptic technique applies.